ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO934

Effects of Curcuma longa L. and Green Propolis Extract-Loaded Microcapsules Supplementation on Inflammation in Hemodialysis Patients

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1500 Health Maintenance, Nutrition, and Metabolism

Authors

  • Mafra, Denise, Universidade Federal do Rio de Janeiro Centro de Ciencias da Saude, Rio de Janeiro, RJ, Brazil
  • Britto, Isadora, Universidade Federal do Rio de Janeiro Centro de Ciencias da Saude, Rio de Janeiro, RJ, Brazil
  • Ribeiro, Marcia Maria, Universidade Federal do Rio de Janeiro Centro de Ciencias da Saude, Rio de Janeiro, RJ, Brazil
  • de Paiva, Bruna Regis, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil
  • Brito, Jessyca Sousa de, Universidade Federal do Rio de Janeiro Centro de Ciencias da Saude, Rio de Janeiro, RJ, Brazil
  • Teixeira, Karla thais Resende, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil
  • Alvarenga, Livia De almeida, Universidade Federal do Rio de Janeiro Centro de Ciencias da Saude, Rio de Janeiro, RJ, Brazil
  • Couto, Heloiza, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil
  • Chermut, Tuany Ramos, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil
  • Delgado, Virgílio Pimentel, Renal Assistencia Medica, Rio de Janeiro, Brazil
  • Cunha, Danielle Figueiredo, Renal Assistencia Medica, Rio de Janeiro, Brazil
  • Ribeiro-Alves, Marcelo, Fundacao Oswaldo Cruz, Rio de Janeiro, RJ, Brazil
  • Berretta, Andresa, ApisFlora, Ribeirão Preto, Brazil
  • Cardozo, Ludmila Fmf, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil
  • Leite, Paulo emílio Corrêa, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil

Group or Team Name

  • Renal Nutrition - UFF.
Background

Nutritional interventions with food that contains bioactive compounds such as Curcuma longa L. and propolis can mitigate inflammation in patients with CKD on hemodialysis (HD). Although broadly available, there are limitations in using these bioactive compounds when ingested in their traditional forms. In this way, the microencapsulation process of these natural compounds can be a good alternative. This longitudinal, double-blind, placebo-controlled study aims to evaluate the effects of Curcuma longa L. and green propolis extract-loaded microcapsules supplementation on inflammatory markers in HD patients.

Methods

Patients were randomized into two groups: Intervention (137mg/d of Curcuma longa L. and 500mg/d of concentrated and standardized green propolis extract EPP-AF®, Apis Flora, Brazil) as microcapsules administrated hard vegetable capsules or placebo for eight weeks. The levels of inflammatory biomarkers (IL-5, GM-CSF, TNF-α, IL-1B, IL-13, IL-4, MCP-1, IL-8, MIP-1, IL-10, G-CSF, IL-7, IL-12 and IL-17) were analyzed by multiplex assay (Bio-Plex Magpix®). C-reactive protein (CRP) was analyzed using a Bioclin device. All analyses were adjusted according to age, sex, BMI and time on HD.

Results

38 patients completed the study; 18 patients in the intervention group (49 ± 18.6 yr.; BMI 21.6 ± 5.2Kg/m2; 8 men) and 20 in the placebo group (49 ± 16.2 yr.; BMI 24.4 ± 3.4Kg/m2; 10 men). After supplementation, MIP-1 and CRP plasma levels were significantly reduced (Fig 1).

Conclusion

Supplementation with 137 mg/d of Curcuma longa L. and 500mg of microencapsulated EPP-AF® green propolis extract in hemodialysis patients for eight weeks significantly reduced MIP-1 and CRP values, evidencing the potential anti-inflammatory effects of the supplement.

Fig 1. There was evidence of reduced plasma levels of MIP-1 (A) and CRP (B) after microcapsules with turmeric and propolis supplementation.

Funding

  • Government Support – Non-U.S.